Search Results

Displaying Results 526-550 of 1160 "'PD'"

Mar 30, 2026, 09:00 ET Aurzen stellt den tragbaren EAZZE D1 Air vor, der einfaches Smart TV mit integriertem Streaming und USB-C-Stromversorgung bietet

Ein versenkter USB-C-Anschluss mit 65-W-PD-Unterstützung ermöglicht den Betrieb des D1 Air über gängige Laptop-Ladegeräte oder tragbare Powerbanks, sodass es problemlos von Raum zu Raum transportiert

More news about: Aurzen Official


Mar 30, 2026, 08:00 ET Doble Enhances Mobility and Versatility in Partial Discharge Surveys with Spark P2

Spark P2™, a handheld partial discharge (PD) and radio frequency interference (RFI) measurement device. The Spark P2, a mobile and compact single channel PD surveyor, performs sensitive PD measurements on any test object and any PD sensor, providing advanced PD and RFI insulation system diagnostics and

More news about: Doble Engineering Company


Mar 30, 2026, 08:00 ET BRAINBox Solutions Provides Updates on Clinical, Development, and Corporate Progress in BRAINBox TBI Concussion Diagnostic/Prognostic Test Program

Multimodal Solutions for Precision Testing of Geriatric PatientsAt the annual Emergencies in Medicine conference, March 1-5, and the AD/PD Advances in Science & Therapy Conference, March 19-20, the company presented posters describing a machine-learning based solution for differential

More news about: BRAINBox Solutions, Inc.


Mar 28, 2026, 11:22 ET Prodigy Technovations 增強領先業界的 I3C 協定執行器與分析儀,加入先進的應用層協定 NVMe-MI、SPDM 及 PLDM 支援

PGY-I3C-EX-PD 提供整合平台,可進行協定執行、流量生成、協定解碼及錯誤分析,讓工程師在開發過程中能夠模擬並測試真實應用場景。 此可配置為 I3C 控制器、目標裝置或輔助控制器,支援在多種不同架構下作驗證。此解決方案同時支援內部積體電路 (I2C) 控制器及目標裝置的模擬功能,方便測試現代系統單晶片 (SoC) 設計中常見的 I2C 與 I3C 混合環境。 錯誤注入、邊際測試、協定觸發及連續串流擷取等多項功能,能協助工程師驗證系統通訊是否高效穩健。PGY-I3C-EX-PD 主要功能支援

More news about: Prodigy Technovations


Mar 28, 2026, 08:57 ET 프로디지 테크노베이션스, 고급 애플리케이션 수준 프로토콜 NVMe-MI, SPDM 및 PLDM 지원으로 업계를 선도하는 I3C 프로토콜 엑서사이저 및 분석기 향상

프로디지 테크노베이션(Prodigy Technovations Pvt. Ltd.)가 자사의 PGY-I3C-EX-PD I3C 프로코콜 엑서사이저(Exerciser) 및 분석기를 강화해, 최신 컴퓨팅 플랫폼에서 점점 더 많이 사용되는 상위 관리 프로토콜 지원을 추가했다고 발표했다.  

More news about: Prodigy Technovations


Mar 27, 2026, 16:24 ET Prodigy Technovations Nâng Cấp Thiết Bị Phân Tích và Kiểm Thử Giao Thức I3C hàng đầu trong ngành với khả năng Hỗ Trợ các Giao Thức Cấp Ứng Dụng Nâng Cao NVMe-MI, SPDM và PLDM

vừa công bố các cải tiến cho thiết bị Phân Tích và Kiểm Thử Giao Thức I3C PGY-I3C-EX-PD, bổ sung khả năng hỗ trợ các giao thức quản lý cấp cao vốn đang được sử dụng ngày càng rộng rãi trên các nền tảng điện toán hiện đại.

More news about: Prodigy Technovations


Mar 27, 2026, 07:46 ET Prodigy Technovations、業界をリードするI3Cプロトコル・エクササイザーおよびアナライザーを強化――高度なアプリケーションレベルプロトコルである NVMe-MI、SPDM、PLDMに対応

エラーインジェクションマルチOS対応 Windows、MACos、Linux価格および発売時期強化版PGY-I3C-EX-PD は、今すぐご利用いただけます。評価または価格については、下記までお問い合わせください

More news about: Prodigy Technovations


Mar 27, 2026, 03:19 ET Prodigy Technovations Enhances Industry leading I3C Protocol Exerciser and Analyzer with Advanced Application-Level Protocol NVMe-MI, SPDM and PLDM Support

protocol analysis and validation solutions, announced enhancements to its PGY-I3C-EX-PD I3C Protocol Exerciser and Analyzer, adding support for higher-level management protocols increasingly used in modern computing platforms.

More news about: Prodigy Technovations


Mar 26, 2026, 23:54 ET Akeso Reports Full-Year 2025 Financial Results

III trials, including 5 global studies and 7 head-to-head studies against PD-1/L1 therapies, targeting critical 1L indications, IO-resistant, and "cold" tumors.Cadonilimab (PD-1/CTLA-4):Cadonilimab (PD-1/CTLA-4) is the world's first and only approved bispecific antibody of its class.

More news about: Akeso, Inc.


Mar 26, 2026, 09:32 ET CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

Rapid Advancement Across Core R&D PipelineThe global, multicenter Phase I/II clinical trial of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) is actively enrolling patients in Australia and China, and the Phase II IND application has been approved in the US. CS2009

More news about: CStone Pharmaceuticals


Mar 26, 2026, 09:00 ET New Report: In 2024, Parkinson's Disease Cost the U.S. $82.2 Billion, Surpassing Previous Projections

societal cost to treat PD continue to grow," said James Beck, PhD, executive vice president and chief scientific officer at the Parkinson's Foundation. "This new study further underscores the extreme financial burden to not only society, but to the families of those living with PD. Parkinson's remains one

More news about: The Michael J. Fox Foundation for Parkinson's Research


Mar 26, 2026, 08:53 ET CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

containing CTLA-4 and PD-(L)1 were observed, and the incidence of Grade ≥3 VEGF-related AEs was low.Compelling Efficacy in Lung Cancer: CS2009 monotherapy demonstrates potentially transformative Phase I/II efficacy in Non-Small Cell Lung Cancer (NSCLC). In first-line NSCLC (PD-L1 tumor proportion

More news about: CStone Pharmaceuticals


Mar 26, 2026, 08:01 ET DJI 正式發表 8K 全景旗艦無人機 DJI Avata 360:暢遊天際,縱覽全域

高速無線傳輸,無需單獨取出,使用者透過 DJI Fly App 在藍牙有效範圍內即可喚醒裝置並下載素材,傳輸速率最高可達 100MB/s[1],1GB 素材約 10 秒即可完成傳輸。另外,在續航方面,DJI Avata 360 擁有最長 23 分鐘[1]的飛行時間,支援搭配充電管家實現 PD 快充與多電池並充,快速恢復電量,助力使用者持續創作,捕捉靈感不間斷。發售與服務DJI Avata 360(DJI RC 2)售價 NT$ 20,190 / HK$ 4,989;DJI Avata 360 暢飛套裝(DJI RC 2)售價

More news about: DJI


Mar 26, 2026, 07:00 ET BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

progressive GBM and other high-grade glioma. The objective is to establish a maximum tolerated dose (MTD) and/or a recommended dose based on safety, PK/PD and preliminary efficacy. Data from the Phase 1 part of the trial are anticipated in H1 2027.The Phase 2a expansion part of the trial is planned

More news about: BioLineRx Ltd.


Mar 26, 2026, 06:00 ET Innovent Announces 2025 Annual Results and Business Updates

estimates, these late-stage assets target a combined total addressable market (TAM) of over US$60 billion, including:IBI363 (PD-1/IL-2α-bias): Next-gen IO cornerstone, potential TAM over US$40 billion for first wave of indicationsIn collaboration

More news about: Innovent Biologics


Mar 26, 2026, 05:43 ET Prodigy Technovations améliore son testeur et analyseur de protocole I3C, leader du secteur, en y ajoutant la prise en charge avancée des protocoles de niveau application NVMe-MI, SPDM et PLDM

améliorations apportées à son outil d'analyse et d'exercice de protocoles I3C PGY-I3C-EX-PD, en ajoutant la prise en charge de protocoles de gestion de haut niveau de plus en plus utilisés dans les plateformes informatiques modernes.

More news about: Prodigy Technovations


Mar 26, 2026, 03:46 ET Fosun International's MSCI ESG Rating Upgraded to AAA, Reaching a Record High

broadly benefit patients worldwide. Henlius' independently developed HANSIZHUANG (serplulimab, European trade name: Hetronifly®), the world's first anti-PD-1 monoclonal antibody approved for first-line treatment of small cell lung cancer (SCLC), has been approved in Europe and multiple emerging markets for

More news about: Fosun


Mar 26, 2026, 03:10 ET Prodigy Technovations erweitert branchenführenden I3C Protocol Exerciser and Analyzer um fortschrittliche Unterstützung für NVMe-MI, SPDM und PLDM auf Anwendungsebene

Lösungen für Protokollanalyse und Validierung, gab Erweiterungen für seinen PGY-I3C-EX-PD I3C Protocol Exerciser and Analyzer bekannt und erweiterte damit die Unterstützung für übergeordnete Managementprotokolle, die auf modernen Rechenplattformen

More news about: Prodigy Technovations


Mar 25, 2026, 23:30 ET Prodigy Technovations Enhances Industry leading I3C Protocol Exerciser and Analyzer with Advanced Application-Level Protocol NVMe-MI, SPDM and PLDM Support

protocol analysis and validation solutions, announced enhancements to its PGY-I3C-EX-PD I3C Protocol Exerciser and Analyzer, adding support for higher-level management protocols increasingly used in modern computing platforms.

More news about: Prodigy Technovations


Mar 25, 2026, 09:00 ET Prodigy Technovations Enhances Industry leading I3C Protocol Exerciser and Analyzer with Advanced Application-Level Protocol NVMe-MI, SPDM and PLDM Support

protocol analysis and validation solutions, announced enhancements to its PGY-I3C-EX-PD I3C Protocol Exerciser and Analyzer, adding support for higher-level management protocols increasingly used in modern computing platforms.

More news about: Prodigy Technovations


Mar 25, 2026, 08:30 ET Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

is expected to provide sufficient extracorporeal anticoagulation while minimally affecting systemic ACT. In conclusion, nafamostat has unique PK and PD properties, making it a suitable candidate for further evaluation as a regional anticoagulant in CRRT."While we are currently enrolling patients

More news about: Talphera, Inc.


Mar 25, 2026, 08:05 ET Erayak Strategic Roadmap: Providing a High-Precision Energy Defense Against Global Oil and Grid Volatility

Verified Success: The 4500PD Dual-Fuel Inverter is currently available and market-verified across Amazon, official websites, and global retail channels.6800 Series Pre-sale: Official pre-sales for the next-generation 6800PT/PD series will launch in May 2026.

More news about: Erayak Power Solution Group Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.